Risk of non-melanoma skin cancer associated with use of hydrochlorothiazide

A Dear Healthcare Professional Letter has been issued by the Health Sciences Authority (HSA), in consultation with its Product Vigilance Advisory Committee, to update healthcare professionals on the outcome of its review regarding the risk of non-melanoma skin cancer (NMSC) associated with hydrochlorothiazide (HCTZ) use. HSA is working with the companies to strengthen the local package inserts of HCTZ-containing products to warn of the potential risk of NMSC.
Healthcare professional, Therapeutic Products

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.moh.gov.sg/hpp/, and follow the procedures below to access the MOH Alert system.

Step 1: On the top navigation ribbon of webpage, select 'For Healthcare Professionals' followed by 'Health Professionals Portal' and click on the choice of profession. User will be redirected to the specific HPP webpage for the selected profession.

Step 2: Click on the Restricted Content icon on the left panel of webpage and login via SingPass.

Step 3: Click on the MOH Alert icon under ‘Applications’ section

Step 4: Click on the Drug Alert tab to view the DHCPLs.